FUSN

Fusion Pharmaceuticals Inc. Common Shares

Delisted

FUSN was delisted on the 3rd of June, 2024.

29 hedge funds and large institutions have $88.8M invested in Fusion Pharmaceuticals Inc. Common Shares in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$158K
2 +$98.5K
3 +$59.2K
4
UBS Group
UBS Group
Switzerland
+$24.5K
5
Renaissance Technologies
Renaissance Technologies
New York
+$21.1K

Top Sellers

1 -$1.12M
2 -$184K
3 -$152K
4
UOC
UBS O'Connor
Illinois
-$52K
5
Citadel Advisors
Citadel Advisors
Florida
-$50.4K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$11.6M
2
$10.2M
3
$10.2M
4
$9.82M
5
$9.29M
6
$8.48M
7
$8.04M
8
$6.3M
9
$4.92M
10
$2.36M
11
$2.31M
12
$2.08M
13
$1.04M
14
$820K
15
$369K
16
$340K
17
$197K
18
$180K
19
$137K
20
$79K
21
$74K
22
$39.4K
23
$26K
24
$3.01K
25
$3K